Skip to main content
. 2022 Apr 19;126(11):1548–1554. doi: 10.1038/s41416-022-01737-2

Fig. 3. Forest plot of overall survival (OS) by subgroup.

Fig. 3

C-B capecitabine plus bevacizumab, CI confidence interval, ECOG PS Eastern Cooperative Oncology Group performance status, HR hazard ratio, TT-B trifluridine/tipiracil plus bevacizumab.